# VieCure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/viecure

- Industry: Healthcare IT
- Headquarters: Greenwood Village, US
- Website: www.viecure.com
- Total disclosed funding: $70M
- Latest round: Series A (Sep 30, 2024)
- Investors on record: 1

## About

Founded in 2015 in Greenwood Village, US, Viviphi Ltd, doing business as VieCure develops an AI platform aimed at improving cancer treatment. In January 2026, VieCure raised USD 43 million in venture funding co-led by Northpond Ventures and an individual investor, with participation from Durable Capital Partners, Socium Ventures, and Sator Grove Holdings.
VieCure offers an artificial intelligence platform designed to enhance cancer care through personalized patient management and treatment optimization. Their core product serves as a comprehensive cancer knowledge base, integrating clinical data, genomic insights, and treatment protocols to empower healthcare providers in delivering precision medicine. The platform facilitates improved patient outcomes by enabling providers to make informed decisions based on real-time insights and evidence-based guidelines. VieCure's offerings are primarily aimed at oncology practices, including over 80 contracted cancer center locations across North America. The end users of these services are healthcare providers, such as oncologists and clinical staff, who utilize the platform to streamline workflows, enhance patient engagement, and ultimately improve the financial performance of their practices.

## Funding rounds

- Series A, Sep 30, 2024, $45M — Northpond Ventures
- Series A, Apr 20, 2021, $25M — Northpond Ventures

## Investors

- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Series A